arrow
S

Steven J. Gray

UT Southwestern Medical Center
H指数:44
被引数:7,868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Vyas et al. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. Int. J. Mol. Sci. 2023, 24, 14611

更正:Vyas等人. 腺相关病毒血清型9介导的基因疗法对AB变异型GM2神经节苷脂贮积症的疗效。Int. J. Mol. Sci. 2023, 24, 14611

2026-04-010
OAAI
First-in-human high dose AAV9 intrathecal gene therapy for paediatric CLN7 disease: a phase 1, open-label, single ascending dose, non-randomised clinical trial

首次人体高剂量AAV9鞘内基因治疗儿童CLN7病:一项1期、开放标签、单次递增剂量、非随机临床试验

2025-11-270
OAAI
Age-sensitive response of systemic AAV-mediated gene therapy in a newly characterized feline model of mucolipidosis II

系统性AAV介导的基因治疗在一种新表征的黏脂贮积症II型猫模型中的年龄敏感性反应

2025-04-240
PRE
AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient

针对50型遗传性痉挛性截瘫的AAV基因治疗:单例患者I期临床试验

2024-06-283
OA
Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies

鞘内注射AAV9/AP4M1基因治疗遗传性痉挛性截瘫50在临床前研究中显示出安全性和有效性

2023-05-1513
OAAI